357.15
+1.55
+(0.44%)
At close: January 30 at 3:45:46 PM GMT+5:30
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 12 | 13 |
| Avg. Estimate | 0 | 0 | 4.28 | 10.3 |
| Low Estimate | 0 | 0 | 2 | 4.7 |
| High Estimate | 0 | 0 | 8.35 | 14.8 |
| Year Ago EPS | -- | 5.31 | 8.62 | 4.28 |
Revenue Estimate
| Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 19 | 19 |
| Avg. Estimate | 41.82B | 40.23B | 153.86B | 182.24B |
| Low Estimate | 40.7B | 40.23B | 148.08B | 167.16B |
| High Estimate | 42.65B | 40.23B | 167.56B | 204.29B |
| Year Ago Sales | 39.17B | 34.33B | 147.56B | 153.86B |
| Sales Growth (year/est) | 6.75% | 17.19% | 4.27% | 18.45% |
Earnings History
| Currency in INR | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.1 | 1.33 | 0.35 | 1 |
| EPS Actual | 1.18 | 5.31 | -0.19 | 0.13 |
| Difference | 0.08 | 3.98 | -0.54 | -0.87 |
| Surprise % | 7.39% | 300.67% | -153.77% | -86.88% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 4.28 | 10.3 |
| 7 Days Ago | 0 | 0 | 3.91 | 10.3 |
| 30 Days Ago | 0 | 0 | 3.92 | 10.43 |
| 60 Days Ago | 0 | 0 | 3.92 | 10.36 |
| 90 Days Ago | 0 | 0 | 3.74 | 10.17 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BIOCON.BO | -- | -- | -50.36% | 140.73% |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Related Tickers
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
GYX.F Futura Medical plc
0.3500
+1.74%
1BT.F Enlivex Therapeutics Ltd.
1.0500
-1.87%
1GDA.F Zevra Therapeutics, Inc.
7.45
0.00%
HQ1.MU Oruka Therapeutics Inc. R
11.40
+1.79%
2GH.BE Merus NV
39.60
-1.00%
CVAC.VI CureVac N.V.
3.7580
-0.63%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4620
-1.70%
471A.F aTyr Pharma, Inc.
3.4600
+5.49%